• Publié par : Fabienne LETELLIER-NICOLAS
  • Imprimer cette page

Publications

2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003

 

2009

  • Classe, J.M., Bordes, V., Campion, L., Mignotte, H., Dravet, F., Levêque, J., Sagan, C., Dupré, P.F., Body, G., Giard, S. Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiothérapie Néoadjuvante, a French prospective multicentric study. J Clin Oncol. 2009. 27 : 726-732.
  • Coutant, C., Olivier, C., Fondrinier, E., Marchal, F., Guillemin, F., Seince, N., Thomas, V., Lambaudie, E., Levêque, J., Barranger, E., Daraï, E., Uzan, S., Houvenaeghel, G., Rouzier, R. Comparison of models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: a prospective multi-center study. J Clin Oncol 2009. 27 : 2800-2808.
  • Desfrancois, J., Derre, L., Corvaisier, M., Le Mevel, B.  Catros, V., Jotereau, F., Gervois, N. Increased frequency of non conventional double positive CD4CD8 ab T cells in human breast pleural effusions. Int J. Cancer 2009. 125 : 374-380.
  • D’Halluin, F., Tas, P., Rouquette, S., Bendavid, C., Foucher, F., Mesbah, H., Blanchot, J., Coué, O., Levêque, J. Intra-Operative Touch Preparation Cytology following lumpectomy for breast cancer: a series of 400 procedure. Breast 2009. 18 : 248-253.
  • Jaffré, F., Lavoué, V., Mesbah, H., Rouquette, S., Audrain, O., Laurent, J.F., Levêque, J. Prognosis for isolated skin recurrence after breast cancer treated by mastectomy. Anticancer Res 2009. 29:1697-1701.
  • Thedrez, A., Harly, C., Morice, A., Salot, S., Bonneville, M., Scotet, E. IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy. J Immunol. 2009. 182 : 3423-3431.
  • Toutirais, O., Cabillic F., Le Friec, G., Salot, S., Loyer, P., Le Gallo, M., Desille, M., Thomas de la Pintière, C., Daniel, P., Bouet, F., Catros, V. iDNAX accessory molecule-1 (CD226) promotes human hepatcellular carcinoma cell lysis by Vγ9Vδ2 T cells. Eur J Immunol. 2009. 39: 1361-1368.
  • Troadec, M.B., Lainé, F., Daniel, V., Rochcongar, P., Ropert, M., Cabillic, F., Perrin, M., Morcet, J., Loréal, O., Olbina, G., Westerman, M., Nemeth, E., Ganz, T., Brissot, P. Daily regulation of serum and urinary hepcidin is not influenced by submaximal cycling exercise in humans with normal iron metabolism. Eur J Appl Physiol. 2009. 106: 435-443.